| Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude R Dobson, S Ramagopalan, A Davis, G Giovannoni Journal of Neurology, Neurosurgery & Psychiatry 84 (8), 909-914, 2013 | 476 | 2013 |
| The pathogenesis of tuberculous meningitis AG Davis, UK Rohlwink, A Proust, AA Figaji, RJ Wilkinson Journal of leukocyte biology 105 (2), 267-280, 2019 | 170 | 2019 |
| Proprioceptive integration and body representation: insights into dancers’ expertise C Jola, A Davis, P Haggard Experimental brain research 213, 257-265, 2011 | 143 | 2011 |
| Treatment of tuberculous meningitis and its complications in adults A Davis, G Meintjes, RJ Wilkinson Current treatment options in neurology 20, 1-15, 2018 | 102 | 2018 |
| Corticosteroids as an adjunct to tuberculosis therapy C Schutz, AG Davis, B Sossen, RPJ Lai, M Ntsekhe, YXR Harley, ... Expert review of respiratory medicine 12 (10), 881-891, 2018 | 67 | 2018 |
| Switching patients at high risk of PML from natalizumab to another disease-modifying therapy G Giovannoni, M Marta, A Davis, B Turner, S Gnanapavan, K Schmierer Practical neurology 16 (5), 389-393, 2016 | 54 | 2016 |
| Antidiabetic activity of extract and compounds from an endophytic fungus Nigrospora oryzae PF Uzor, PO Osadebe, NJ Nwodo Drug research 67 (05), 308-311, 2017 | 52 | 2017 |
| Change practice now! Using atraumatic needles to prevent post lumbar puncture headache A Davis, R Dobson, S Kaninia, M Espasandin, A Berg, G Giovannoni, ... European journal of neurology 21 (2), 305-311, 2014 | 49 | 2014 |
| Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis AG Davis, S Nightingale, PE Springer, R Solomons, A Arenivas, ... Wellcome open research 4, 2019 | 36 | 2019 |
| Management of intracranial tuberculous mass lesions: how long should we treat for? S Marais, R Van Toorn, FC Chow, A Manesh, OK Siddiqi, A Figaji, ... Wellcome open research 4, 2019 | 34 | 2019 |
| Recent developments in tuberculous meningitis pathogenesis and diagnostics FV Cresswell, AG Davis, K Sharma, RB Roy, AR Ganiem, E Kagimu, ... Wellcome open research 4, 2019 | 32 | 2019 |
| Plasma pharmacokinetics of high-dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial S Wasserman, A Davis, C Stek, M Chirehwa, S Botha, R Daroowala, ... Antimicrobial agents and chemotherapy 65 (8), 10.1128/aac. 00140-21, 2021 | 31 | 2021 |
| Cerebrospinal fluid and urinary biomarkers in multiple sclerosis R Dobson, J Topping, A Davis, E Thompson, G Giovannoni Acta Neurologica Scandinavica 128 (5), 321-327, 2013 | 25 | 2013 |
| Knowledge gaps and research priorities in tuberculous meningitis JA Seddon, R Wilkinson, R Van Crevel, A Figaji, GE Thwaites, ... Wellcome Open Research 4, 2019 | 22 | 2019 |
| Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa E Du Bruyn, C Stek, R Daroowala, Q Said-Hartley, M Hsiao, G Schafer, ... Nature communications 14 (1), 188, 2023 | 21 | 2023 |
| Atraumatic needles for lumbar puncture: why haven't neurologists changed? A Davis, R Dobson, S Kaninia, G Giovannoni, K Schmierer Practical neurology 16 (1), 18-22, 2016 | 21 | 2016 |
| A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus–associated … AG Davis, S Wasserman, C Stek, M Maxebengula, C Jason Liang, ... Clinical Infectious Diseases 76 (8), 1412-1422, 2023 | 18 | 2023 |
| Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III … T Maitre, M Bonnet, A Calmy, M Raberahona, RA Rakotoarivelo, ... Trials 23 (1), 928, 2022 | 18 | 2022 |
| Key considerations in the pharmacotherapy of tuberculous meningitis S Wasserman, A Davis, RJ Wilkinson, G Meintjes Expert opinion on pharmacotherapy 20 (15), 1791-1795, 2019 | 16 | 2019 |
| Host directed therapies for tuberculous meningitis AG Davis, J Donovan, M Bremer, R Van Toorn, J Schoeman, A Dadabhoy, ... Wellcome Open Research 5, 2020 | 14 | 2020 |
